2025 North America Breast Augmentation Market Revenue Opportunities Report
Description
The 2025 North America Breast Augmentation Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Breast Augmentation Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the breast augmentation market in North America are Johnson & Johnson (Mentor division), Allergan (owned by AbbVie), Sientra, Inc., and GC Aesthetics. Johnson & Johnson's Mentor division holds about a 21% market share, offering a comprehensive range of silicone and saline implants known for clinical reliability and extensive use worldwide. Allergan leads with approximately 23% market share, manufacturing the Natrelle line of silicone gel and saline implants with innovative product features and a strong global presence. Sientra, specializing in high-strength cohesive silicone gel implants, has expanded its product portfolio with FDA approvals, emphasizing safety and aesthetic outcomes. GC Aesthetics also maintains a significant U.S. market share by focusing on advanced technologies and efficient procedures, partly driven by increasing reconstructive surgeries post-mastectomy.
North America's dominance in the breast augmentation market is supported by rising cosmetic surgery rates, advanced healthcare infrastructure, and a strong regulatory environment ensuring product safety. In 2022 alone, over 255,200 breast augmentations were performed in the U.S., reflecting high demand. Market growth is fueled by technological innovation, including next-generation implants like Motiva with microchip technology for safety monitoring. Additionally, mergers and acquisitions are reshaping the market landscape, with companies like Johnson & Johnson and Allergan sustaining leadership through strategic expansion and product development. The region’s focus on patient safety, evolving beauty standards, and reimbursement policies further consolidate North America's leadership in this sector.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Breast Augmentation Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the breast augmentation market in North America are Johnson & Johnson (Mentor division), Allergan (owned by AbbVie), Sientra, Inc., and GC Aesthetics. Johnson & Johnson's Mentor division holds about a 21% market share, offering a comprehensive range of silicone and saline implants known for clinical reliability and extensive use worldwide. Allergan leads with approximately 23% market share, manufacturing the Natrelle line of silicone gel and saline implants with innovative product features and a strong global presence. Sientra, specializing in high-strength cohesive silicone gel implants, has expanded its product portfolio with FDA approvals, emphasizing safety and aesthetic outcomes. GC Aesthetics also maintains a significant U.S. market share by focusing on advanced technologies and efficient procedures, partly driven by increasing reconstructive surgeries post-mastectomy.
North America's dominance in the breast augmentation market is supported by rising cosmetic surgery rates, advanced healthcare infrastructure, and a strong regulatory environment ensuring product safety. In 2022 alone, over 255,200 breast augmentations were performed in the U.S., reflecting high demand. Market growth is fueled by technological innovation, including next-generation implants like Motiva with microchip technology for safety monitoring. Additionally, mergers and acquisitions are reshaping the market landscape, with companies like Johnson & Johnson and Allergan sustaining leadership through strategic expansion and product development. The region’s focus on patient safety, evolving beauty standards, and reimbursement policies further consolidate North America's leadership in this sector.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
